Role of Toll‐like receptors in the pathogenesis of COVID‐19
S Khanmohammadi, N Rezaei - Journal of medical virology, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), has led to a pandemic since March 2020. The …
syndrome coronavirus 2 (SARS‐CoV‐2), has led to a pandemic since March 2020. The …
A systematic review of pregnant women with COVID-19 and their neonates
Abstract Background In December 2019, a novel coronavirus disease (COVID-19) emerged
in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of …
in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of …
The acid sphingomyelinase/ceramide system in COVID-19
J Kornhuber, N Hoertel, E Gulbins - Molecular Psychiatry, 2022 - nature.com
Acid sphingomyelinase (ASM) cleaves sphingomyelin into the highly lipophilic ceramide,
which forms large gel-like rafts/platforms in the plasma membrane. We showed that SARS …
which forms large gel-like rafts/platforms in the plasma membrane. We showed that SARS …
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
E Roohi, N Jaafari, F Hashemian - Journal of neuroinflammation, 2021 - Springer
Many patients with major depressive disorder (MDD) are reported to have higher levels of
multiple inflammatory cytokines including interleukin 6 (IL-6). Recent studies both pre …
multiple inflammatory cytokines including interleukin 6 (IL-6). Recent studies both pre …
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
G Lisco, A De Tullio, E Jirillo, VA Giagulli… - Journal of …, 2021 - Springer
Background Thyroid dysfunction has been observed in patients with COVID-19, and
endocrinologists are requested to understand this clinical issue. Pandemic-related …
endocrinologists are requested to understand this clinical issue. Pandemic-related …
Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID‐19—Mechanisms and Therapeutic Targets
The outbreak of the COVID‐19 pandemic represents an ongoing healthcare emergency
responsible for more than 3.4 million deaths worldwide. COVID‐19 is the disease caused by …
responsible for more than 3.4 million deaths worldwide. COVID‐19 is the disease caused by …
The role of IL-6 and IL-6 blockade in COVID-19
N Potere, A Batticciotto, A Vecchié… - Expert review of …, 2021 - Taylor & Francis
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a
dysregulated hyperinflammatory response. Areas covered Authors review evidence on IL-6 …
dysregulated hyperinflammatory response. Areas covered Authors review evidence on IL-6 …
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
K Mohamed, N Yazdanpanah, A Saghazadeh… - Bioorganic …, 2021 - Elsevier
Background Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak,
there has been an increasing interest in finding a potential therapeutic agent for the disease …
there has been an increasing interest in finding a potential therapeutic agent for the disease …
[HTML][HTML] Metabolic syndrome and COVID-19
H Yanai - Cardiology research, 2020 - ncbi.nlm.nih.gov
Recent studies showed that comorbidities such as diabetes, hypertension and obesity
contribute to severe and worse outcomes of coronavirus disease 2019 (COVID-19) …
contribute to severe and worse outcomes of coronavirus disease 2019 (COVID-19) …
Ivermectin shows clinical benefits in mild to moderate COVID19: a randomized controlled double-blind, dose-response study in Lagos
OE Babalola, CO Bode, AA Ajayi… - … Journal of Medicine, 2021 - academic.oup.com
Introduction In vitro studies have shown the efficacy of Ivermectin (IV) to inhibit the SARS—
CoV-2 viral replication, but questions remained as to in-vivo applications. We set out to …
CoV-2 viral replication, but questions remained as to in-vivo applications. We set out to …